The Case for Laboratory Developed Procedures

Author:

Kaul Karen L.1,Sabatini Linda M.1,Tsongalis Gregory J.23,Caliendo Angela M.4,Olsen Randall J.5,Ashwood Edward R.6,Bale Sherri7,Benirschke Robert1,Carlow Dean8,Funke Birgit H.9,Grody Wayne W.10,Hayden Randall T.11,Hegde Madhuri12,Lyon Elaine13,Murata Kazunori8ORCID,Pessin Melissa8,Press Richard D.14,Thomson Richard B.1

Affiliation:

1. Department of Pathology and Laboratory Medicine, NorthShore University HealthSystem, Evanston, IL, USA

2. Laboratory for Clinical Genomics and Advanced Technology, Department of Pathology, Dartmouth Hitchcock Medical Center and Norris Cotton Cancer Center, Lebanon, NH, USA

3. Laboratory Medicine, Dartmouth Hitchcock Medical Center and Norris Cotton Cancer Center, Lebanon, NH, USA

4. Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA

5. Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA

6. Department of Pathology, University of Colorado, Aurora, CO, USA

7. GeneDx, Gaithersburg, MD, USA

8. Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

9. Laboratory for Molecular Medicine, Massachusetts General Hospital, Boston, MA, USA

10. Departments of Pathology and Laboratory Medicine, Pediatrics and Human Genetics, UCLA School of Medicine, Los Angeles, CA, USA

11. Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN, USA

12. Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA

13. Pathology Department, University of Utah School of Medicine/ARUP Laboratories, Salt Lake City, UT, USA

14. Department of Pathology and Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA

Abstract

An explosion of knowledge and technology is revolutionizing medicine and patient care. Novel testing must be brought to the clinic with safety and accuracy, but also in a timely and cost-effective manner, so that patients can benefit and laboratories can offer testing consistent with current guidelines. Under the oversight provided by the Clinical Laboratory Improvement Amendments, laboratories have been able to develop and optimize laboratory procedures for use in-house. Quality improvement programs, interlaboratory comparisons, and the ability of laboratories to adjust assays as needed to improve results, utilize new sample types, or incorporate new mutations, information, or technologies are positive aspects of Clinical Laboratory Improvement Amendments oversight of laboratory-developed procedures. Laboratories have a long history of successful service to patients operating under Clinical Laboratory Improvement Amendments. A series of detailed clinical examples illustrating the quality and positive impact of laboratory-developed procedures on patient care is provided. These examples also demonstrate how Clinical Laboratory Improvement Amendments oversight ensures accurate, reliable, and reproducible testing in clinical laboratories.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3